Pfizer
PFE
PFE
2,909 hedge funds and large institutions have $131B invested in Pfizer in 2023 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 1,181 increasing their positions, 1,375 reducing their positions, and 207 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,909
Holders Change
-116
Holders Change %
-3.83%
% of All Funds
46.38%
Holding in Top 10
52
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+1.96%
% of All Funds
0.83%
New
126
Increased
1,181
Reduced
1,375
Closed
207
Calls
$2.43B
Puts
$2.65B
Net Calls
-$222M
Net Calls Change
+$422M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$545M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$310M |
| 3 |
Two Sigma Advisers
New York
|
+$269M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$236M |
| 5 |
D.E. Shaw & Co
New York
|
+$221M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$558M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$388M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$330M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$246M |
| 5 |
BlackRock
New York
|
-$207M |
